AERIE PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Durham, NC
SEC filing record 1 source field available
Fiscal year end
31 December
AERIE PHARMACEUTICALS INC has filed 818 SEC EDGAR filings since 26 Aug 2005

SEC filing history

Showing 751-775 of 815 matching filings.

Per page
25
Current page
31
8-K File 001-36152

FORM 8-K

Filing date
27 Jan 2014
Reporting date
27 Jan 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36152

FORM 8-K

Filing date
09 Jan 2014
Reporting date
09 Jan 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36152

FORM 8-K

Filing date
20 Dec 2013
Reporting date
18 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36152

8-K

Filing date
04 Dec 2013
Reporting date
04 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

OWNERSHIP DOCUMENT

Filing date
25 Nov 2013
Reporting date
25 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A SUBMISSION

Filing date
19 Nov 2013
Reporting date
25 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-87680

SCHEDULE 13D

Filing date
12 Nov 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-87680

SC 13D filing

Filing date
12 Nov 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-87680

SCHEDULE 13D

Filing date
08 Nov 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-87680

SCHEDULE 13D

Filing date
04 Nov 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Nov 2013
Reporting date
30 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Nov 2013
Reporting date
30 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Nov 2013
Reporting date
30 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Nov 2013
Reporting date
30 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Nov 2013
Reporting date
30 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Nov 2013
Reporting date
30 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
01 Nov 2013
Reporting date
30 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-192030

FORM S-8

Filing date
31 Oct 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36152

8-K

Filing date
31 Oct 2013
Reporting date
30 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

IPO FORM 4

Filing date
30 Oct 2013
Reporting date
25 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-191219

FINAL PROSPECTUS

Filing date
28 Oct 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
28 Oct 2013
Reporting date
25 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
25 Oct 2013
Reporting date
25 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
25 Oct 2013
Reporting date
25 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .